MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ

Real-time Quotes | Nasdaq Last Sale

124.84
+2.82
+2.31%
After Hours: 124.84 0 0.00% 16:45 08/07 EDT
OPEN
121.79
PREV CLOSE
122.02
HIGH
125.00
LOW
121.37
VOLUME
225.82K
TURNOVER
--
52 WEEK HIGH
144.49
52 WEEK LOW
58.72
MARKET CAP
4.42B
P/E (TTM)
44.23
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average MEDP stock price target is 118.40 with a high estimate of 125.00 and a low estimate of 113.00.

EPS

MEDP News

More
The Zacks Analyst Blog Highlights: Houghton Mifflin Harcourt Company, CoreLogic, FTI Consulting, Artisan Partners Asset Management and Medpace Holdings
The Zacks Analyst Blog Highlights: Houghton Mifflin Harcourt Company, CoreLogic, FTI Consulting, Artisan Partners Asset Management and Medpace Holdings
Zacks · 13h ago
Insider Weekends: Another Purchase In The Energy Sector
Seeking Alpha - Article · 4d ago
3 Reasons Why Medpace (MEDP) Is a Great Growth Stock
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
Zacks · 07/31 16:45
Insiders Roundup: Tetraphase Pharmaceuticals, Bank of America
GuruFocus News · 07/31 13:09
Medpace Holdings, Inc. Common Stock (MEDP) Q2 2020 Earnings Call Transcript
MotleyFool.com · 07/28 22:31
Medspace Holdings (MEDP) Investor Presentation - Slideshow
Seeking Alpha · 07/28 21:50
Medpace Stock Soars To Record High On Improving Outlook
Medpace Holdings stock soared Tuesday to a record high after the provider of clinical testing and research services for drugmakers late Monday forecast better-than-expected revenue for 2020.
Investor's Business Daily · 07/28 20:18
Medpace cheers Q2 revenue & EPS beat
Seeking Alpha · 07/28 18:31

Industry

Biotechnology & Medical Research
-0.18%
Pharmaceuticals & Medical Research
+0.08%

Hot Stocks

Symbol
Price
%Change

About MEDP

Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
More

Webull offers kinds of Medpace Holdings Inc stock information, including NASDAQ:MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.